Cargando…
Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
OBJECTIVE: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. METHODS: Mexican adults (N=2,511) were recruited from...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743111/ https://www.ncbi.nlm.nih.gov/pubmed/29317841 http://dx.doi.org/10.2147/DMSO.S129247 |
_version_ | 1783288509876928512 |
---|---|
author | DiBonaventura, Marco D Meincke, Henrik Le Lay, Agathe Fournier, Janine Bakker, Erik Ehrenreich, Allison |
author_facet | DiBonaventura, Marco D Meincke, Henrik Le Lay, Agathe Fournier, Janine Bakker, Erik Ehrenreich, Allison |
author_sort | DiBonaventura, Marco D |
collection | PubMed |
description | OBJECTIVE: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. METHODS: Mexican adults (N=2,511) were recruited from a combination of Internet panels and street intercepts using a random-stratified sampling framework, with strata defined by age and sex, so that they represent the population. Participants responded to a survey consisting of a range of topics including sociodemographics, health history, health-related quality of life (HRQoL), work productivity, health care resource use, and weight loss. RESULTS: The sample consisted of 50.6% male with a mean age of 40.7 years (SD=14.5); 38.3% were overweight, and 24.4% were obese. Increasing body mass index (BMI) was associated with increased rates of type 2 diabetes, prediabetes, and hypertension, poorer HRQoL, and decreased work productivity. Of the total number of respondents, 62.2% reported taking steps to lose weight with 27.6% and 17.1% having used an over-the-counter/herbal product and a prescription medication, respectively. Treatment discontinuation rates were high. CONCLUSION: Findings indicated that 62% of participants reported, at least, being overweight and that they were experiencing the deleterious effects associated with higher BMI despite the desire to lose weight. Given the rates of obesity, and its impact on humanistic and societal outcomes, improved education, prevention, and management could provide significant benefits. |
format | Online Article Text |
id | pubmed-5743111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57431112018-01-09 Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences DiBonaventura, Marco D Meincke, Henrik Le Lay, Agathe Fournier, Janine Bakker, Erik Ehrenreich, Allison Diabetes Metab Syndr Obes Original Research OBJECTIVE: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. METHODS: Mexican adults (N=2,511) were recruited from a combination of Internet panels and street intercepts using a random-stratified sampling framework, with strata defined by age and sex, so that they represent the population. Participants responded to a survey consisting of a range of topics including sociodemographics, health history, health-related quality of life (HRQoL), work productivity, health care resource use, and weight loss. RESULTS: The sample consisted of 50.6% male with a mean age of 40.7 years (SD=14.5); 38.3% were overweight, and 24.4% were obese. Increasing body mass index (BMI) was associated with increased rates of type 2 diabetes, prediabetes, and hypertension, poorer HRQoL, and decreased work productivity. Of the total number of respondents, 62.2% reported taking steps to lose weight with 27.6% and 17.1% having used an over-the-counter/herbal product and a prescription medication, respectively. Treatment discontinuation rates were high. CONCLUSION: Findings indicated that 62% of participants reported, at least, being overweight and that they were experiencing the deleterious effects associated with higher BMI despite the desire to lose weight. Given the rates of obesity, and its impact on humanistic and societal outcomes, improved education, prevention, and management could provide significant benefits. Dove Medical Press 2017-12-22 /pmc/articles/PMC5743111/ /pubmed/29317841 http://dx.doi.org/10.2147/DMSO.S129247 Text en © 2018 DiBonaventura et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research DiBonaventura, Marco D Meincke, Henrik Le Lay, Agathe Fournier, Janine Bakker, Erik Ehrenreich, Allison Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
title | Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
title_full | Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
title_fullStr | Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
title_full_unstemmed | Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
title_short | Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
title_sort | obesity in mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743111/ https://www.ncbi.nlm.nih.gov/pubmed/29317841 http://dx.doi.org/10.2147/DMSO.S129247 |
work_keys_str_mv | AT dibonaventuramarcod obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT meinckehenrik obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT lelayagathe obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT fournierjanine obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT bakkererik obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT ehrenreichallison obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences |